V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250002104 | 250008584 | 1.87 | 82.4 | null | null | 2019-12-07 | NIVOLUMAB | null | null | NIVOLUMAB | 101714991 |
| 250002113 | 250008587 | 1.53 | 88.8 | null | null | 2020-07-16 | null | null | null | CARBOPLATIN + GEMCITABINE | 100126209 |
| 250002129 | 250008590 | 1.75 | 87.8 | null | null | 2020-07-13 | GemCarbo Days 1+8 | null | null | CARBOPLATIN + GEMCITABINE | 100892019 |
| 250002130 | 250008591 | 0 | 75 | null | null | 2020-11-16 | Cisplatin + Gemcitabine (D 1 & 8) | null | null | NIVOLUMAB | 100761352 |
| 250002136 | 250008593 | 1.72 | 61.6 | null | null | 2020-07-13 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 100529938 |
| 250002145 | 250008595 | 1.66 | 98.9 | Palliative (P) | 2020-09-21 | 2020-10-05 | NIVOLUMAB | 02 | null | NIVOLUMAB | 101472386 |
| 250002153 | 250008596 | 1.57 | 65 | null | null | 2021-03-08 | null | null | null | CARBOPLATIN + GEMCITABINE | 100292841 |
| 250002154 | 250008597 | 1.69 | 88.8 | null | null | 2017-01-09 | Cisplatin + Gemcitabine (D 1 & 8) | null | null | NIVOLUMAB | 100338236 |
| 250002168 | 250008599 | 1.53 | 80 | null | null | 2020-11-15 | GemCarbo Days 1+8 | null | null | CARBOPLATIN + GEMCITABINE | 100434701 |
| 250002169 | 250008600 | 1.71 | 108.4 | Palliative (P) | null | 2022-02-05 | null | 2 | null | CARBOPLATIN | 100876897 |
| 250002180 | 250008601 | null | null | Palliative (P) | 2018-08-22 | 2018-09-04 | AVAPRITINIB | 02 | null | CISPLATIN | 101795528 |
| 250002223 | 250008606 | 1.69 | 14.6 | Curative (C) | null | 2018-08-27 | Cisplatin + Radiotherapy | Y | N | PEMETREXED | 101307704 |
| 250002227 | 250008607 | 1.64 | 72.3 | null | 2020-08-20 | 2020-09-03 | Doxorubicin 75mg/m2 | 02 | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100248687 |
| 250002237 | 250008610 | 1.83 | 45.4 | Palliative (P) | 2020-05-22 | 2020-05-22 | null | 02 | null | DOCETAXEL + GEMCITABINE | 100773104 |
| 250002245 | 250008613 | null | null | null | null | 2018-03-18 | CARBOPLATIN + FLUOROURACIL | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN | 100936287 |
| 250002247 | 250008614 | 1.61 | 82.4 | Palliative (P) | 2020-07-27 | 2020-08-03 | Pazopanib | null | null | CISPLATIN | 100741886 |
| 250002251 | 250008616 | 1.92 | 66 | Palliative (P) | 2019-07-30 | 2019-08-06 | Fluorouracil+Mitomycin+RT (Bladder) | null | null | TRIAL UNSPECIFIED | 100520843 |
| 250002254 | 250008617 | null | null | null | null | 2020-08-11 | AFATINIB | null | null | CARBOPLATIN + FLUOROURACIL | 100575057 |
| 250002261 | 250008619 | 1.67 | 45.2 | Curative (C) | 2016-07-04 | 2016-07-04 | null | N | N | TRABECTEDIN | 100634456 |
| 250002263 | 250008620 | 1.65 | 47.2 | Palliative (P) | null | 2018-02-28 | REGORAFENIB | 02 | N | OLAPARIB | 100975579 |
| 250002269 | 250008621 | 1.77 | 91.3 | Palliative (P) | 2021-10-21 | 2021-10-21 | Cisplatin | 02 | null | DOXORUBICIN | 101137375 |
| 250002280 | 250008626 | 1.6 | 62 | Palliative (P) | 2016-11-25 | 2016-12-02 | CYCLOPHOSPHAMIDE + VINORELBINE | 02 | N | CAPECITABINE + OXALIPLATIN | 100171267 |
| 250002294 | 250008628 | 1.53 | 81 | Neo-adjuvant (N) | 2018-07-02 | 2018-09-18 | null | 02 | N | IMATINIB | 101014106 |
| 250002309 | 250008631 | 1.62 | 21.4 | Palliative (P) | 2019-01-04 | 2019-03-28 | FLUOROURACIL + IRINOTECAN | N | N | ENZALUTAMIDE | 101720961 |
| 250002313 | 250008632 | 0.9 | 13.1 | Neo-adjuvant (N) | 2019-07-04 | 2019-07-06 | null | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 101535452 |
| 250002319 | 250008633 | null | null | Palliative (P) | 2019-05-12 | 2019-05-28 | Pemetrexed | 02 | N | TEMOZOLOMIDE | 101205298 |
| 250002332 | 250008635 | 1.01 | 54 | Adjuvant (A) | 2018-03-15 | 2018-04-18 | null | 02 | N | WT GUIDELINES CYCLOPHOS/DOXORUBICIN | 101666138 |
| 250002333 | 250008636 | 1.63 | 69 | Curative (C) | 2021-05-21 | 2021-05-26 | NB HRNBL-1 ch14.18/CHO only (trial) | 02 | null | RUCAPARIB | 101519263 |
| 250002334 | 250008637 | 1.84 | 70.5 | null | 2019-12-16 | 2020-01-13 | null | 02 | N | TRIAL UNSPECIFIED | 101637139 |
| 250002335 | 250008638 | 1.65 | 53.9 | null | 2020-02-26 | 2020-04-05 | Trial Unspecified | 01 | N | CAPECITABINE | 100304734 |
| 250002342 | 250008639 | 1.71 | 67.35 | Adjuvant (A) | 2021-04-06 | 2021-07-25 | IPILIMUMAB + NIVOLUMAB | 02 | N | FLUOROURACIL + OXALIPLATIN | 100644136 |
| 250002344 | 250008640 | 0 | 49.6 | null | 2020-12-01 | 2020-12-08 | STS Rhabdo RMS 2005 Vin Cyclo | 02 | N | FLUOROURACIL | 101069981 |
| 250002360 | 250008644 | 1.67 | 127 | null | 2020-10-12 | 2020-10-18 | LIPOSOMAL DOXORUBICIN | 02 | null | CARBOPLATIN + PACLITAXEL | 101227963 |
| 250002363 | 250008645 | null | null | null | 2021-09-12 | 2021-09-24 | null | null | null | PACLITAXEL | 100936005 |
| 250002381 | 250008647 | 1.75 | 65.85 | Curative (C) | null | 2019-01-23 | Trial Unspecified | null | null | NB HRNBL-1 COJEC IND COURSE A | 101735266 |
| 250002399 | 250008650 | 1.6 | 65.5 | Palliative (P) | 2017-04-25 | 2017-05-02 | null | N | N | ICON8B TRIAL | 100263626 |
| 250002405 | 250008651 | 1.57 | 108.4 | null | 2015-04-29 | 2017-05-24 | Cisplatin + Radiotherapy | 02 | null | CARBOPLATIN + FLUOROURACIL | 100133184 |
| 250002407 | 250008652 | null | null | Curative (C) | null | 2022-05-28 | null | null | N | LOMUSTINE + PROCARBAZINE + VINCRISTINE | 100650076 |
| 250002410 | 250008653 | 1.49 | 52 | Palliative (P) | 2020-02-24 | 2020-03-09 | BLEOMYCIN + CISPLATIN + VINCRISTINE | 02 | null | BEVACIZUMAB | 101773111 |
| 250002412 | 250008654 | 1.66 | 69.5 | Palliative (P) | null | 2018-10-05 | CAP | null | N | CARBOPLATIN | 101613599 |
| 250002413 | 250008655 | null | null | Palliative (P) | 2021-08-20 | 2021-08-23 | Fluorouracil+Mitomycin+RT (Bladder) | 02 | null | CARBOPLATIN + PEMETREXED | 100158875 |
| 250002414 | 250008656 | 1.66 | 84.2 | Curative (C) | null | 2020-02-12 | AVELUMAB + AXITINIB | 2 | N | AVELUMAB | 100241738 |
| 250002430 | 250008657 | 1.6 | 69.5 | null | 2019-10-06 | 2019-10-21 | Oxaliplatin + Modified de Gramont | N | null | ATEZOLIZUMAB | 100584231 |
| 250002434 | 250008658 | 1.53 | 154 | 03 | 2019-11-22 | 2020-01-19 | Cetuximab + CISPLATIN + FLUOROURACIL | 02 | null | DINUTUXIMAB BETA | 101792055 |
| 250002460 | 250008660 | 1.87 | 14.9 | Palliative (P) | 2021-10-15 | 2021-10-29 | Sunitinib | Y | N | CISPLATIN + PEMETREXED | 100235580 |
| 250002472 | 250008661 | 1.61 | 122.8 | null | 2022-02-25 | 2022-03-07 | EC | 02 | null | TRIAL UNSPECIFIED | 100498184 |
| 250002493 | 250008663 | null | 0 | Adjuvant (A) | 2019-11-15 | 2019-11-30 | Capecitabine + Oxaliplatin 21day | 02 | null | CARBOPLATIN + PACLITAXEL | 100390503 |
| 250002496 | 250008664 | 1.6 | 0 | null | 2021-08-05 | 2021-08-06 | null | 01 | N | CARBOPLATIN + ETOPOSIDE | 101022174 |
| 250002499 | 250008666 | 1.69 | 132.2 | Curative (C) | 2019-01-10 | 2019-01-24 | CETUXIMAB | 02 | N | DOXORUBICIN | 101290057 |
| 250002502 | 250008667 | 1.71 | 82.9 | Palliative (P) | 2020-11-09 | 2020-11-22 | Capecitabine + Oxaliplatin 21day | 02 | null | WT SIOP 2002 01 POST OP CARBO, ETOP | 100633098 |